Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

End Stage Chronic Renal Failure clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

End Stage Chronic Renal Failure: 1 US clinical trial tracked, none currently recruiting.

End Stage Chronic Renal Failure is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Vanderbilt University Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition end-stage-chronic-renal-failure

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%End Stage Chronic Renal (th…0%
Open-enrollment share among volume-matched conditions near End Stage Chronic Renal Failure

End Stage Chronic Renal Failure has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for End Stage Chronic Renal Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. End Stage Chronic Renal Failure is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on End Stage Chronic Renal Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

10˚C deceased donor kidney storage using Traferox XPort Device
1 trials

US sites by state

Facility locations filed on End Stage Chronic Renal Failure trials. A trial with sites in several states counts in each.

Tennessee 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this End Stage Chronic Renal Failure page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No End Stage Chronic Renal Failure trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Vanderbilt University Medical Center sponsors the most End Stage Chronic Renal Failure trials on record, review their full trial history before evaluating a specific study. See Vanderbilt University Medical Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This End Stage Chronic Renal Failure condition card totals 1 registered trials; most-linked intervention 10˚C deceased donor kidney storage using Traferox XPort; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.